Rheumatological diseases and pulmonary manifestations, what you need to know

被引:1
|
作者
Saavedra, Silvana [1 ,2 ]
Reyes-Cartes, Felipe [3 ,4 ,5 ]
机构
[1] Hosp Clin Fuerza Aerea Chile, Dept Med Interna, Unidad Reumatol, Santiago, Chile
[2] Clin Indisa, Unidad Reumatol, Dept Med Interna, Santiago, Chile
[3] Clin Las Condes, Ctr Resp & Cirugia Torax, Santiago, Chile
[4] Unidad Paciente Crit, Clin Las Condes, Santiago, Chile
[5] Inst Nacl Torax, Unidad Patol Intersticial, Santiago, Chile
来源
REVISTA MEDICA CLINICA LAS CONDES | 2024年 / 35卷 / 3-4期
关键词
Connective Tissue Diseases; Rheumatoid Arthritis; Idiopathic Inflammatory Myopathy; Systemic Sclerosis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Pulmonary Manifestations; Interstitial Lung Disease; INTERSTITIAL LUNG-DISEASE; SYSTEMIC-SCLEROSIS; RHEUMATOID-ARTHRITIS; ARTERIAL-HYPERTENSION; DOUBLE-BLIND; SCLERODERMA; TOCILIZUMAB; FEATURES; SAFETY; TRIAL;
D O I
10.1016/j.rmclc.2024.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Connective tissue diseases and vasculitis are a wide group of autoimmune pathologies that can affect multiple organs. One of the most frequently affected systems is the respiratory system, with compromise of the airway, lung parenchyma, pleura and mediastinum. These pathologies constitute an important cause of morbimortality, making it essencial to maintain a high clinical suspicion. Furthermore, it is of vital relevance to rule out other causes of affectation like adverse drug reactions and infections due to the immunosuppressed state of patients with rheumatic diseases. Both the classification and its management must be done by a multidisciplinary team, based on the clinical history, serology, lung function tests, high-resolution computed tomography, bronchoalveolar lavage and/or biopsy, depending on each case. This review article aims to highlight the importance of a multidisciplinary approach in the management of connective tissue diseases and vasculitis; complex pathologies that can affect the respiratory system, constituting an important cause of morbidity and mortality. The classification and management of these conditions should be carried out by a multidisciplinary team, based on clinical status, laboratory tests, pulmonary function tests, imaging studies, and biopsies, according to each case.
引用
收藏
页码:262 / 272
页数:11
相关论文
共 50 条
  • [1] Pulmonary Manifestations in Rheumatological Diseases
    Aurangabadkar, Gaurang M.
    Aurangabadkar, Milind Y.
    Choudhary, Sumer S.
    Ali, Saood N.
    Khan, Shafee M.
    Jadhav, Ulhas S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [2] Autoimmune brain diseases: what you need to know
    McKeon, Andrew
    Dalmau, Josep
    Graus, Francesc
    LANCET NEUROLOGY, 2022, 21 (10): : 875 - 875
  • [3] Sexually transmitted diseases in the elderly: What you need to know
    Letvak, S
    Schoder, D
    GERIATRIC NURSING, 1996, 17 (04) : 156 - 160
  • [4] YOU KNOW WHAT YOU NEED
    RHODES, WL
    INFOSYSTEMS, 1985, 32 (06): : 10 - 10
  • [5] Do you know what you need to know?
    Bartold, PM
    AUSTRALIAN DENTAL JOURNAL, 2004, 49 (04) : 161 - 161
  • [6] WE NEED TO KNOW WHAT YOU NEED TO KNOW
    不详
    HOSPITALS, 1977, 51 (22): : 57 - 57
  • [7] 'WHAT YOU NEED TO KNOW'
    CHARACH, R
    EVENT, 1981, 10 (01): : 30 - 31
  • [8] Sexually transmitted diseases: A physician tells you what you need to know.
    Bibel, BM
    LIBRARY JOURNAL, 1998, 123 (20) : 145 - 145
  • [9] Pulmonary sialadenoma papilliferum and its mimics: what you need to know
    Gao, H. W.
    Sun, P-L
    HISTOPATHOLOGY, 2022, 81 (06) : 715 - 723
  • [10] Radiation What it is, what you need to know
    Tangen, Jon-Magnus
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (15) : 1387 - 1387